JP2022514463A5 - - Google Patents

Info

Publication number
JP2022514463A5
JP2022514463A5 JP2021531881A JP2021531881A JP2022514463A5 JP 2022514463 A5 JP2022514463 A5 JP 2022514463A5 JP 2021531881 A JP2021531881 A JP 2021531881A JP 2021531881 A JP2021531881 A JP 2021531881A JP 2022514463 A5 JP2022514463 A5 JP 2022514463A5
Authority
JP
Japan
Prior art keywords
stereocomplex
group
cancer
tumor
pdla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021531881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514463A (ja
JP7580378B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/064140 external-priority patent/WO2020117742A1/en
Publication of JP2022514463A publication Critical patent/JP2022514463A/ja
Priority to JP2024034842A priority Critical patent/JP7772847B2/ja
Publication of JP2022514463A5 publication Critical patent/JP2022514463A5/ja
Application granted granted Critical
Publication of JP7580378B2 publication Critical patent/JP7580378B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531881A 2018-12-04 2019-12-03 抗がん剤の送達のためのステレオコンプレックス Active JP7580378B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024034842A JP7772847B2 (ja) 2018-12-04 2024-03-07 抗がん剤の送達のためのステレオコンプレックス

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862775076P 2018-12-04 2018-12-04
US62/775,076 2018-12-04
US201962893863P 2019-08-30 2019-08-30
US62/893,863 2019-08-30
PCT/US2019/064140 WO2020117742A1 (en) 2018-12-04 2019-12-03 Stereocomplexes for the delivery of anti-cancer agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024034842A Division JP7772847B2 (ja) 2018-12-04 2024-03-07 抗がん剤の送達のためのステレオコンプレックス

Publications (3)

Publication Number Publication Date
JP2022514463A JP2022514463A (ja) 2022-02-14
JP2022514463A5 true JP2022514463A5 (https=) 2024-03-18
JP7580378B2 JP7580378B2 (ja) 2024-11-11

Family

ID=69147760

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021531881A Active JP7580378B2 (ja) 2018-12-04 2019-12-03 抗がん剤の送達のためのステレオコンプレックス
JP2024034842A Active JP7772847B2 (ja) 2018-12-04 2024-03-07 抗がん剤の送達のためのステレオコンプレックス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024034842A Active JP7772847B2 (ja) 2018-12-04 2024-03-07 抗がん剤の送達のためのステレオコンプレックス

Country Status (10)

Country Link
US (2) US12029792B2 (https=)
EP (2) EP3891207B1 (https=)
JP (2) JP7580378B2 (https=)
KR (1) KR20210107029A (https=)
CN (2) CN113260653B (https=)
AU (2) AU2019394855B2 (https=)
CA (1) CA3121902A1 (https=)
MX (2) MX2021006557A (https=)
TW (1) TWI744730B (https=)
WO (1) WO2020117742A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113289062B (zh) * 2021-05-17 2022-08-30 辽宁省计划生育科学研究院 一种溶剂沉淀型原位凝胶注射植入剂及应用
JP2023043944A (ja) * 2021-09-17 2023-03-30 国立大学法人金沢大学 腫瘍治療用医薬組成物
WO2023204581A1 (ko) * 2022-04-20 2023-10-26 동국대학교 산학협력단 암세포 사멸효과를 가지는 3d 하이드로젤 복합체 및 이의 제조방법

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251382B1 (en) 1998-04-17 2001-06-26 Enzon, Inc. Biodegradable high molecular weight polymeric linkers and their conjugates
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CA2388063C (en) 1999-11-24 2010-06-08 Immunogen, Inc. Cytotoxic agents comprising taxanes and their therapeutic use
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
ES2387886T3 (es) 2001-11-13 2012-10-03 Celator Pharmaceuticals, Inc. Composiciones que transportan lípidos con una mejor estabilidad sanguínea
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US6596757B1 (en) 2002-05-14 2003-07-22 Immunogen Inc. Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
US7691962B2 (en) 2004-05-19 2010-04-06 Medarex, Inc. Chemical linkers and conjugates thereof
US20060018872A1 (en) * 2004-06-16 2006-01-26 Tew Gregory N Poly(lactic acid) copolymer hydrogels and related methods of drug delivery
KR20070120156A (ko) 2005-04-15 2007-12-21 이뮤노젠 아이엔씨 종양에서 이종 또는 혼성 세포 집단의 제거 방법
EP1951239A2 (en) 2005-10-25 2008-08-06 Celator Pharmaceuticals, Inc. Fixed ratio drug combination treatments for solid tumors
PT1948180E (pt) 2005-11-11 2013-05-10 Boehringer Ingelheim Int Tratamento de combinação de cancro compreendendo inibidores de egfr/her2
TWI412367B (zh) 2006-12-28 2013-10-21 梅達雷克斯有限責任公司 化學鏈接劑與可裂解基質以及其之綴合物
PL3300601T3 (pl) 2007-02-16 2022-05-02 Rotalec Ip Holdings Llc Ustalone stosunki leków do leczenia nowotworów hematopoetycznych i zaburzeń proliferacyjnych
DK2644194T3 (en) 2008-03-18 2017-07-03 Genentech Inc Combinations of an anti-HER2 antibody-drug conjugate and docetaxel
NZ610239A (en) 2008-04-30 2014-11-28 Immunogen Inc Cross-linkers and their uses
CN104244988A (zh) 2012-03-05 2014-12-24 雷蒙特亚特特拉维夫大学有限公司 结合治疗活性剂的聚合物、其制备方法以及其用途
US9504756B2 (en) 2012-05-15 2016-11-29 Seattle Genetics, Inc. Self-stabilizing linker conjugates
CN103772686B (zh) * 2012-10-26 2015-01-07 苏州雷纳药物研发有限公司 一种两亲性嵌段共聚物及其制备方法、以及该共聚物与抗肿瘤药物形成的胶束载药系统
CN107614019A (zh) 2015-03-09 2018-01-19 加利福尼亚大学董事会 用于组合抗癌疗法的聚合物‑药物结合物
CN105031672A (zh) * 2015-07-14 2015-11-11 同济大学 一种聚乳酸立构复合物磁性纳米胶束的制备方法
WO2017158499A1 (en) * 2016-03-14 2017-09-21 Wisconsin Alumni Research Foundation Oligolactic acid conjugates and micelles with enhanced anticancer efficacy
KR101949013B1 (ko) * 2016-03-22 2019-02-18 한양대학교 에리카산학협력단 다중 약물 제어 방출을 위한 폴리락타이드 광학이성질체의 스테레오 복합체에 기초한 생분해성 이방성 나노입자
CN106139160B (zh) 2016-07-29 2019-02-19 苏州大学 透明质酸衍生化的美登素前药、其制备方法与在制备肿瘤靶向治疗药物中的应用
CN106581691B (zh) 2016-12-04 2019-09-10 苏州大学 还原响应的靶向聚乙二醇-聚碳酸酯美登素前药胶束、其制备方法与应用

Similar Documents

Publication Publication Date Title
JP7772847B2 (ja) 抗がん剤の送達のためのステレオコンプレックス
Hoang et al. Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells
US20240366519A1 (en) Nanoparticle delivery systems
US11612570B2 (en) Decreased adhesivity receptor-targeted nanoparticles for Fn14-positive tumors
CN105147613A (zh) 增强药物递送和治疗剂有效性的方法
CN101965201B (zh) 淋巴管内化疗药物载体
JP2011231122A (ja) 薬物−担体複合体およびその使用方法
ES2832802T3 (es) Sistemas de administración dirigida del particulado específico de una estructura
JP2022514463A5 (https=)
Wei et al. Nanomedicine and drug delivery
Jeswani et al. Advances in the delivery of cancer therapeutics: a comprehensive review
JP2022552841A (ja) ポリマー薬物送達コンジュゲートならびにそれを作製および使用する方法
HK40078343B (zh) 用於递送抗癌剂的立体复合物
HK40078343A (en) Stereocomplexes for the delivery of anti-cancer agents
HK40049681B (en) Stereocomplexes for the delivery of anti-cancer agents
HK40049681A (en) Stereocomplexes for the delivery of anti-cancer agents
EP2878312A1 (en) Reversible PEGylation of nanocarriers
HK40086650A (zh) 用於治疗癌症和癌症耐药性的脂质体制剂
Tucci Improved Pancreatic Cancer Therapy Using Engineered Gemcitabine Nanoparticles